We are live on ! Find out more
ADAP

Adaptimmune Therapeutics

Delisted

ADAP was delisted on the 27th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
76
Tower Research Capital (TRC)
New York
$23K -$17K -1,360 -41%
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$12K -$200 -16 -2%
KBC Group
78
KBC Group
Belgium
$11K
OAJ
79
Ogorek Anthony Joseph
New York
$11K
SMFS
80
Squar Milner Financial Services
California
$8K +$8.04K +645 New
RE
81
RBC Europe
United Kingdom
$7.12K
SFM
82
Signet Financial Management
New Jersey
$7K +$6.86K +550 New
Parallax Volatility Advisers
83
Parallax Volatility Advisers
California
$4K -$12.5K -1,000 -77%
Daiwa Securities Group
84
Daiwa Securities Group
Japan
$4K
ASN
85
Advisory Services Network
Georgia
$2K +$798 +64 +64%
RCAG
86
Rehmann Capital Advisory Group
Michigan
$570
Fidelity International
87
Fidelity International
Bermuda
-$7.49M -666,891 Closed
AA
88
ALPS Advisors
Colorado
-$1.41M -125,655 Closed
ARTA
89
A.R.T. Advisors
New York
-$953K -84,925 Closed
GCP
90
GSA Capital Partners
United Kingdom
-$852K -75,912 Closed
Susquehanna International Group
91
Susquehanna International Group
Pennsylvania
-$678K -54,405 Closed
OAM
92
Oxford Asset Management
United Kingdom
-$565K -50,337 Closed
BFM
93
Boothbay Fund Management
New York
-$380K -33,851 Closed
D.E. Shaw & Co
94
D.E. Shaw & Co
New York
-$352K -31,367 Closed
Acadian Asset Management
95
Acadian Asset Management
Massachusetts
-$309K -27,508 Closed
MA
96
MYDA Advisors
New York
-$213K -19,009 Closed
Jane Street
97
Jane Street
New York
-$168K -14,947 Closed
CIP
98
Convergence Investment Partners
Florida
-$4K -350 Closed